Pharma

Sanofi has en­list­ed drug dis­cov­ery com­pa­ny Al­loy Ther­a­peu­tics to de­vel­op an an­ti­sense oligonu­cleotide drug for a sin­gle, undis­closed cen­tral ner­vous sys­tem tar­get. Sanofi will pay

Aet­na is go­ing af­ter an­oth­er phar­ma­ceu­ti­cal com­pa­ny for al­leged price fix­ing. The health in­sur­ance provider filed suit against Take­da on Fri­day over what it says

New an­ti-obe­si­ty drugs should meet a min­i­mum lev­el of weight loss to be con­sid­ered for ap­proval, the FDA said Tues­day, tak­ing the rare step of

A bas­ket study for ex­per­i­men­tal ALS treat­ments record­ed a pair of ad­di­tion­al fail­ures on Mon­day from two promi­nent com­pa­nies. New da­ta from Google’s longevi­ty play

Im­muneer­ing’s shares rock­et­ed in pre­mar­ket trad­ing on Tues­day on the back of pos­i­tive mid-stage da­ta for its MEK in­hibitor in pan­cre­at­ic can­cer, spark­ing plans to